cheung wilson waishun  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address  tower lane suite  foster city ca   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwinssretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsdmd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpsd  sclnsciclone pharmaceuticals incdehealthdrugpharmaceutical preparationscheung wilson waishuncaocfosvpmdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfopnewd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfomdd  axtiaxt incdetechsemicnsemiconductors  related devicheung wilson waishuncaocfosdd dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved ﻿ wilson waishun cheung sells  shares of sciclone pharmaceuticals inc scln stock  chaffey breeze daily ratings  news for sciclone pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor sciclone pharmaceuticals inc with our free daily email newsletter follow chaffeybreeze recent posts hawaiian holdings’ ha underweight rating reaffirmed at morgan stanley gilead sciences inc gild upgraded at bidaskclub giii apparel group ltd giii downgraded to sell at bidaskclub o’reilly automotive inc orly position maintained by capital impact advisors llc analysts expect danaher corporation nysedhr will post quarterly sales of  billion analysts set varonis systems inc vrns target price at  critical contrast platform specialty products corporation pah  terravia holdings nasdaqtvia uti worldwide nasdaqutiw  air transport services group atsg head to head survey ultralife corporation nasdaqulbi versus arotech corporation artx head to head contrast contrasting gentiva health services gtiv  addus homecare corporation adus head to head review gaslog lp glog vs golar lng partners gmlp calumet specialty products partners lp clmt rating increased to strongbuy at zacks investment research juno therapeutics inc nasdaqjuno rating increased to buy at zacks investment research eastman chemical company nyseemn expected to post quarterly sales of  billion winnebago industries inc nysewgo earns “market perform” rating from bmo capital markets zimmer biomet holdings inc nysezbh position boosted by advantus capital management inc morgan stanley has  million stake in bwx technologies inc nysebwxt analyzing allot communications allt and zayo group holdings zayo  shares in parsley energy inc pe acquired by two sigma securities llc weiss multi strategy advisers llc takes position in puma biotechnology inc nysepbyi wilson waishun cheung sells  shares of sciclone pharmaceuticals inc scln stock posted by charlotte bryant on jul th   no comments sciclone pharmaceuticals inc nasdaqscln cfo wilson waishun cheung sold  shares of the firm’s stock in a transaction dated monday june th the stock was sold at an average price of  for a total transaction of  following the completion of the transaction the chief financial officer now owns  shares of the company’s stock valued at  the sale was disclosed in a document filed with the securities  exchange commission which is available through the sec website sciclone pharmaceuticals inc scln traded up  during midday trading on friday hitting   shares of the stock were exchanged sciclone pharmaceuticals inc has a month low of  and a month high of  the firm has a day moving average price of  and a day moving average price of  the stock has a market capitalization of  million a pe ratio of  and a beta of  get sciclone pharmaceuticals inc alerts warning “wilson waishun cheung sells  shares of sciclone pharmaceuticals inc scln stock” was first reported by chaffey breeze and is owned by of chaffey breeze if you are accessing this article on another website it was copied illegally and reposted in violation of united states and international copyright and trademark law the original version of this article can be viewed at httpswwwchaffeybreezecomwilsonwaishuncheungsellssharesofsciclonepharmaceuticalsincsclnstockhtml institutional investors have recently modified their holdings of the stock allianz asset management ag raised its position in shares of sciclone pharmaceuticals by  in the fourth quarter allianz asset management ag now owns  shares of the specialty pharmaceutical company’s stock valued at  after buying an additional  shares in the last quarter metropolitan life insurance co ny raised its position in shares of sciclone pharmaceuticals by  in the fourth quarter metropolitan life insurance co ny now owns  shares of the specialty pharmaceutical company’s stock valued at  after buying an additional  shares in the last quarter guggenheim capital llc acquired a new position in shares of sciclone pharmaceuticals during the fourth quarter valued at about  russell investments group ltd acquired a new position in shares of sciclone pharmaceuticals during the fourth quarter valued at about  finally gsa capital partners llp raised its position in shares of sciclone pharmaceuticals by  in the fourth quarter gsa capital partners llp now owns  shares of the specialty pharmaceutical company’s stock valued at  after buying an additional  shares in the last quarter institutional investors and hedge funds own  of the company’s stock separately maxim group set a  price target on shares of sciclone pharmaceuticals and gave the stock a “buy” rating in a research report on thursday may th about sciclone pharmaceuticals sciclone pharmaceuticals inc is a pharmaceutical company the company’s product portfolio of therapies includes oncology infectious diseases and cardiovascular disorders the company’s business is focused primarily in the people’s republic of china the company operates in two segments china and the rest of the world including its operations in the united states and hong kong receive news  ratings for sciclone pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for sciclone pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website wilson waishun cheung  fremont ca  intelius sign in we found wilson waishun cheung in fremont ca wilson waishun cheung intelius found that wilson waishun cheung is a male between  and  years old from fremont ca we have connected them to  addresses  phones and  relatives or associates also known as wilson s cheung get report now age wilson waishun cheung is in his s wilson has lived in fremont ca walnut ca hayward ca wilsons relatives michelle cheung virginia cheung karen cheung philip cheung wilson waishun cheung zodiac signaquarius gendermale get report now want to know more about wilson get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about wilson or use our people search engine to find others get background check on wilson waishun cheung get a criminal check on wilson waishun cheung get a public record report on wilson waishun cheung get a people search report on wilson waishun cheung wilson waishun cheungs contact information known cities lived in find out where wilson waishun cheung has lived as well as wilson waishun cheungs phone numbers and email addresses wilson waishun cheung has lived in  states california address for wilson waishun cheung  l p fremont ca has lived in fremont ca walnut ca get full address report phone numbers associated with wilson waishun cheung    fremont ca    fremont ca    fremont ca get full phone report email addresses associated with wilson waishun cheung wgnet wgcom wgnet get email report wilson waishun cheungs social network and potential email matches find out potential social network profiles and potential email usernamed for wilson waishun cheung wilson waishun cheungs known social networks and potential email matches find all of wilson waishun cheungs social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches wilson cheung username matches wilsoncheung cheungwilson wilsoncheung cheungwilson wilsoncheung cheungwilson wilsoncheung cheungwilson wcheung popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches w cheung intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here sciclone pharmaceuticals scln receives daily news impact score of   watch list news home about staff privacy policy contact headlines business us news health world investing technology sciclone pharmaceuticals inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for sciclone pharmaceuticals inc with our free daily email newsletter follow watchlist news   latest news at home group inc nasdaqhome downgraded to sell at zacks investment research zacks investment research upgrades kcap financial inc kcap to hold htg molecular diagnostics inc nasdaqhtgm upgraded to “hold” at zacks investment research kingfisher plc kgfhy rating lowered to sell at zacks investment research lion biotechnologies inc nasdaqiova upgraded to “buy” at zacks investment research jc decaux sa nasdaqjcdxf rating lowered to sell at zacks investment research hess midstream partners lp nasdaqhesm upgraded to buy by zacks investment research harmonic inc nasdaqhlit lowered to strong sell at zacks investment research gopro inc gpro upgraded by vetr inc to strongbuy alphabet inc googl stock rating lowered by vetr inc zacks investment research upgrades harvest capital credit corporation nasdaqhcap to hold glycomimetics inc glyc stock rating upgraded by zacks investment research zacks investment research lowers galectin therapeutics inc nasdaqgalt to hold nic inc egov upgraded to buy by zacks investment research × inc eght raised to buy at zacks investment research dasan zhone solutions inc dzsi cut to “hold” at zacks investment research dicerna pharmaceuticals inc drna rating lowered to sell at zacks investment research zacks investment research downgrades idi inc nasdaqcogt to sell differential brands group inc dfbg upgraded by zacks investment research to “hold” lululemon athletica inc nasdaqlulu receives new coverage from analysts at needham  company llc archives july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  march  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  sciclone pharmaceuticals scln receives daily news impact score of  july th    comments  filed under  by hanz christensen filed under investing  news sentiment articles tweet media coverage about sciclone pharmaceuticals nasdaqscln has trended positive recently accern sentiment analysis reports the research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources accern ranks coverage of publiclytraded companies on a scale of negative one to positive one with scores closest to one being the most favorable sciclone pharmaceuticals earned a daily sentiment score of  on accern’s scale accern also assigned headlines about the specialty pharmaceutical company an impact score of  out of  meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future sciclone pharmaceuticals scln traded down  during midday trading on monday hitting   shares of the stock traded hands the stock has a day moving average of  and a  day moving average of  sciclone pharmaceuticals has a year low of  and a year high of  the firm has a market cap of  million a pricetoearnings ratio of  and a beta of  separately maxim group restated a “hold” rating on shares of sciclone pharmaceuticals in a research note on thursday june th trademark violation warning this report was first published by watch list news and is owned by of watch list news if you are accessing this report on another site it was illegally stolen and republished in violation of international copyright laws the original version of this report can be read at httpswwwwatchlistnewscomsciclonepharmaceuticalssclnreceivesdailynewsimpactscoreofhtml in other news ceo friedhelm blobel sold  shares of the business’s stock in a transaction on monday april th the shares were sold at an average price of  for a total transaction of  following the completion of the transaction the chief executive officer now owns  shares of the company’s stock valued at  the sale was disclosed in a filing with the sec which is accessible through this hyperlink also cfo wilson waishun cheung sold  shares of the business’s stock in a transaction on monday june th the shares were sold at an average price of  for a total transaction of  following the transaction the chief financial officer now directly owns  shares of the company’s stock valued at approximately  the disclosure for this sale can be found here in the last three months insiders have sold  shares of company stock valued at  corporate insiders own  of the company’s stock about sciclone pharmaceuticals sciclone pharmaceuticals inc is a pharmaceutical company the company’s product portfolio of therapies includes oncology infectious diseases and cardiovascular disorders the company’s business is focused primarily in the people’s republic of china the company operates in two segments china and the rest of the world including its operations in the united states and hong kong receive news  ratings for sciclone pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for sciclone pharmaceuticals inc and related companies with analyst ratings networks free daily email newsletter hanz christensen  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news sirius xm making big investment in pandora tax reform not going quite as planned western digital files lawsuit to halt toshiba chip business sale sinclair broadcast group announces deal for tribune media starbucks has a hit with its unicorn frappuccino  watch list news llc  all rights reserved privacy policy  about  staff  contact cheung wilson waishun top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active cheung wilson waishun • foster city ca how do i update this listing cheung wilson waishun is based out of foster city summary dg insider form  hong kong holdings create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from cheung wilson waishun enter your email address below and choose submit your email cancel contact info cheung wilson waishun sciclone pharmaceuticals inc foster city ca     recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading experimental current hong kong exchange long positions updated daily holder issuer transaction date transaction type avg pps shares involved shares owned  capital origin cheung wai yin wilson merdeka mobile group ltd  long     hong kong position history holder issuer transaction date transaction type avg pps shares involved shares owned  capital origin cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka mobile group ltd  long     hong kong cheung wai yin wilson merdeka resources holdings ltd  long     hong kong cheung wai yin wilson merdeka resources holdings ltd  long     hong kong elevate your investments try it for free sciclone pharmaceuticals inc sclno people  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states sciclone pharmaceuticals inc sclno related topics stocksstock screenermarket datahealthcarepharmaceuticals overview news key developments people charts financials analysts research pulse sclno on nasdaq usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  summary name age since current position jon saxe   independent chairman of the board friedhelm blobel   president chief executive officer director wilson cheung   chief financial officer senior vice president  finance secretary hong zhao   chief executive officer  china operations raymond low   vice president  finance controller lan xie   vice president  finance china chief financial officer nancy chang   independent director richard hawkins   independent director anthony lapointe   independent director simon li   independent director » insider trading biographies name description jon saxe mr jon s saxe jd is an independent chairman of the board of sciclone pharmaceuticals inc since july   he has served as the chairman of our board of directors since july  and as a director since august  mr saxe was president of pdl biopharma inc formerly protein design labs inc from  to early  from  to  mr saxe was president of saxe associates inc consultants to venture capital firms and biotechnology diagnostic and pharmaceutical companies he was the president and ceo of synergen inc a biotechnology company acquired by amgen from  to  mr saxe is former vice president licensing and corporate development and head of patent law for hoffmannlaroche inc where he worked for almost  years mr saxe received his bs che from carnegiemellon university his jd from george washington university school of law and his llm from new york university school of law he serves as a director of other public and private companies including durect corporation and as chairman of vistagen therapeutics inc friedhelm blobel dr friedhelm blobel phd is president chief executive officer director of sciclone pharmaceuticals inc he has served as our president chief executive officer and as a director since june  from july  to  dr blobel was president ceo and a director of gryphon therapeutics inc a south san francisco based biopharmaceutical company prior to joining gryphon therapeutics in july  dr blobel spent more than two decades as an executive with the hoechst group and the boehringer mannheim group including responsibilities in the areas of diabetes and in vitro diagnostics his roles at these companies included group president of several product divisions chief technology officer and general manager in tokyo japan of a marketing and sales joint venture between boehringer and yamanouchi pharmaceuticals now astellas pharma inc senior vice president of research and development diabetes and patient care in mannheim germany as well as in indianapolis indiana dr blobel earned his doctorate degree “drrernat” a phd equivalent with a dissertation in biochemistry and microbiology from the university of hohenheim germany and holds an advanced degree in chemistry from the university of stuttgart germany wilson cheung mr wilson w cheung has been appointed as chief financial officer senior vice president  finance secretary of sciclone pharmaceuticals inc mr cheung joined sciclone in july  and serves as chief financial officer senior vice president finance and secretary prior to joining sciclone from  to  mr cheung served in various positions at velti plc a publicly traded global mobile marketing and advertising softwareasaservice provider including most recently as chief compliance officer asia pacific and previously as chief financial officer from  to  mr cheung served as chief financial officer of axt inc a publicly traded manufacturer of high performance semiconductor substrates mr cheung holds a ba degree in economicsbusiness from the university of california los angeles and is a certified director of corporate governance from ucla’s executive program he is a california certified public accountant inactive hong zhao mr hong zhao has been appointed as chief executive officer  china operations of sciclone pharmaceuticals inc effective april   mr zhao joined sciclone as chief executive officer china operations in april  prior to sciclone from  to  mr zhao served as executive vice president of simcere pharmaceutical group a manufacturer and supplier of pharmaceuticals in china where he was responsible for all business operations and had direct reporting responsibility for medical affairs market access marketing and sales operations training and personnel development prior to simcere from  to  mr zhao held various positions at novartis china a health care products company including most recently senior vice president of novartis greater china and general manager of novartis shanghai mr zhao earned a bachelor of medicine degree from nanjing medical college and an executive masters of business administration degree from china european international business school ceibs in shanghai raymond low mr raymond a low is vice president  finance controller of sciclone pharmaceuticals inc he joined sciclone as vice president finance and controller in october  prior to joining sciclone from  to  mr low served as chief financial officer and from  to  as corporate controller at axt inc a publicly traded manufacturer of high performance semiconductor substrates from  to  mr low was corporate controller of therasense inc now abbott laboratories a health care products company mr low is a california certified public accountant and a member of the california society of cpas he is a past member of the chartered institute of management accountants in the united kingdom mr low has an mba degree from chadwick university alabama a bachelor of accounting science honors degree from the university of south africa and a bachelor of commerce degree from rhodes university south africa lan xie ms lan xie cpa is vice president finance china chief financial officer of sciclone pharmaceuticals inc ms xie joined sciclone as vice president finance china chief financial officer in august  from  to  ms xie served as vice president of finance and investor relations at shangpharma corporation a pharmaceutical company from  to  ms xie served as a senior manager transaction services at pricewaterhousecoopers zhong tian llp in shanghai and from  to  ms xie served as manager mergers and acquisitions at deloitte  touche in new york ms xie also served in various finance and accounting positions at reuters incorporated and pricewaterhousecoopers in boston she is a massachusetts certified public accountant and received her mba from insead singaporefrance nancy chang dr nancy t chang phd is an independent director of sciclone pharmaceuticals inc she has served as a director since september  since  dr chang has served as the president of apex enterprises inc an investment management company with a major focus on healthcare investments from  to  she was the chairperson and senior managing director of caduceus asia partners at orbimed advisors llc from  to  dr chang served as cofounder president and chairman of tanox inc which was sold to genentech in  prior to founding tanox dr chang held several leadership positions at centocor now a division of johnson  johnson she was also an associate professor at baylor college of medicine and before that she worked at the roche institute of molecular biology dr chang received her doctorate in biological chemistry from harvard university richard hawkins mr richard j hawkins is an independent director of sciclone pharmaceuticals inc since october  mr hawkins has served as a director since october  since  mr hawkins has been the president and chief executive officer of lumos pharma inc a privatelyheld company mr hawkins has served as the president and chief executive officer of id inc a privatelyheld company since  and as the chairman and ceo of labnow inc a privatelyheld company he founded that develops labonachip sensor technology to be used in pointofcare diagnostic testing systems since  from  to  mr hawkins cofounded and served as director at corning biopro a protein contract manufacturing firm from  to  mr hawkins cofounded and served as chairman of sensus drug development which developed and received regulatory approval for somavert® a growth hormone antagonist approved for the treatment of acromegaly and now marketed by pfizer in both the united states and europe in  mr hawkins founded pharmaco a clinical research organization cro that in  was merged with the predecessor of ppdpharmaco one of the largest cros in the world today mr hawkins has served as a member of the board of directors of cytori therapeutics inc since  mr hawkins graduated cum laude with a bs in biology from ohio university anthony lapointe mr gregg a lapointe cpa is an independent director of sciclone pharmaceuticals inc since march  mr lapointe has served as a director since march  mr lapointe is currently the chief executive officer of cerium pharmaceuticals inc a specialty pharmaceutical company from april  to february  mr lapointe served as chief executive officer of sigmatau pharmaceuticals inc a pharmaceutical company focused on rare disorders and the us whollyowned subsidiary of sigmatau finanziaria spa he served as chief operating officer of sigmatau pharmaceuticals inc from december  to march  mr lapointe is a certified public accountant in the united states he holds a bachelor of commerce degree from concordia university of montreal a graduate diploma in public accountancy from mcgill university of montreal and an mba from duke university simon li mr simon li is an independent director of sciclone pharmaceuticals inc since january  most recently mr li has served as a director since january  he is currently the chairman and chief executive officer of jw medical system ltd an affiliated company of biosensors international ltd from  to  mr li served in various positions at medtronic a global medical technology company including as the global officer and member of the executive committee of medtronic and president greater china and chairman of the board medtronicweigao jv prior to medtronic from  to  mr li served in various positions at johnson  johnson medical china “jj” including international vice president north asianew business development asia pacificstrategic medical affairs asia pacific earlier in his career with jj he held the positions of international vice president north asia managing director china and hong kong and managing director china prior to jj mr li was president and chief operating officer of the convatec business with bristolmyers squibb in hong kong he also served as general manager of the pharmaceutical distributor yc woo  co ltd in hong kong he earned a bachelor of arts degree in social sciences from the university of hong kong an mba degree from henley management and an advanced emba from harvard business school basic compensation name fiscal year total jon saxe  friedhelm blobel  wilson cheung  hong zhao  raymond low  lan xie  nancy chang  richard hawkins  anthony lapointe  simon li  as of   dec  options compensation name options value jon saxe   friedhelm blobel   wilson cheung   hong zhao   raymond low   lan xie   nancy chang   richard hawkins   anthony lapointe   simon li   insider trading name shares traded price blobel friedhelm   blobel friedhelm   blobel friedhelm   blobel friedhelm   blobel friedhelm   blobel friedhelm   blobel friedhelm   blobel friedhelm   xie lan   cheung wilson wai shun   blobel friedhelm   zhao hong   zhao hong   cheung wilson wai shun   blobel friedhelm   zhao hong   low raymond anthony cpa   xie lan   cheung wilson wai shun   cheung wilson wai shun   cheung wilson wai shun   zhao hong   zhao hong   blobel friedhelm   zhao hong   » full list on insider trading related topics stocksstock screenermarket datahealthcarepharmaceuticals